Celldex Therapeutics (CLDX) P/E (2010 - 2026)
Celldex Therapeutics (CLDX) P/E from Jun 30, 2010 to Jul 20, 2026. The TTM Celldex Therapeutics (CLDX) P/E is -8.30. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Celldex Therapeutics (CLDX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -8.30 | +19.05% |
| 2025 | -6.98 | -34.23% |
| 2024 | -10.60 | -29.47% |
| 2023 | -15.04 | -23.67% |
| 2022 | -19.70 | -17.19% |
| 2021 | -23.79 | +158.81% |
| 2020 | -9.19 | +1330.24% |
| 2019 | -0.64 | +232.36% |
| 2018 | -0.19 | -93.42% |
| 2017 | -2.94 | +7.45% |
| 2016 | -2.73 | -77.53% |
| 2015 | -12.16 | -12.09% |
| 2014 | -13.83 | -103.98% |
| 2013 | 347.22 | -639.68% |
| 2012 | -64.34 | +158.08% |
| 2011 | -24.93 | -52.70% |
| 2010 | -52.71 | N/A |
Comparison Celldex Therapeutics (CLDX) P/E with competitors
Celldex Therapeutics (CLDX) P/E is -8.30.